To study the molecular pathways promoting the development of hepatocellular carcinoma and/or accelerate tumor formation, similar composite transposon vectors can be developed that co-express another oncogene (such as cMyc or an activated β-catenin) together with Cre39, 40. This evidence concerns the gene MYC and hepatocellular carcinoma.